Brivaracetam is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onset seizures.
All Products protected by valid patents is for laboratory analytical/research purposes only and is not offered for sale in countries or area where the sale of this product constitutes a patent infringement, its liability is at buyer's risk!
Brivaracetam (CAS: 294076-13-0) is a high-potency antiepileptic drug derived from levetiracetam. Synthesized via advanced catalytic methods, its molecular formula is C13H20N2O2. This compound acts as a selective ligand for synaptic vesicle protein 2A.
Strictly contraindicated in patients with known hypersensitivity to the molecule. Store in cool, dry environments below 25°C to maintain chemical stability. Clinical use requires monitoring for dizziness and somnolence.